Literature DB >> 12663476

Is podocyte injury relevant in diabetic nephropathy? Studies in patients with type 2 diabetes.

Michele Dalla Vestra1, Alessandra Masiero, Anna Maria Roiter, Alois Saller, Gaetano Crepaldi, Paola Fioretto.   

Abstract

Podocyte structural changes have been suggested to be involved in the pathogenesis of albuminuria in diabetes. We evaluated podocytes density, number, and structure in 67 white patients with type 2 diabetes: 21 normoalbuminuric (NA), 23 microalbuminuric (MA), and 23 proteinuric (P). Kidney function and biopsy studies were performed; 20 kidney donors served as control subjects. Electron microscopic morphometric analysis was used to estimate numerical density of podocytes per glomerulus [Nv(epi/glom)], filtration slit length density per glomerulus (FSLv/glom), and foot process width (FPW). The number of podocytes per glomerulus (Epi N/glom) was obtained by multiplying Nv(epi/glom) by mean glomerular volume. Nv(epi/glom) was significantly decreased in all type 2 diabetic groups compared with control subjects and was lower in MA and P than in NA (P < 0.0001, ANOVA). Epi N/glom was lower in MA and P patients compared with control subjects (P < 0.002, ANOVA); however, there were no significant differences among the type 2 diabetic groups. In addition, MA and P had decreased FSLv/glom and increased FPW compared with NA (P < 0.005 for both, ANOVA). The albumin excretion rate was inversely related to Nv(epi/glom) and FSLv/glom and directly to FPW (P < 0.0005 for all), whereas there was no correlation with Epi N/glom. In conclusion, changes in podocyte structure and density occur since the early stages of diabetic nephropathy and might contribute to increasing albuminuria in type 2 diabetic patients. These findings also suggest that in white type 2 diabetic patients, the density of podocytes may be functionally more relevant than the absolute number.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12663476     DOI: 10.2337/diabetes.52.4.1031

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  99 in total

1.  Angiotensin II-dependent persistent podocyte loss from destabilized glomeruli causes progression of end stage kidney disease.

Authors:  Akihiro Fukuda; Larysa T Wickman; Madhusudan P Venkatareddy; Yuji Sato; Mahboob A Chowdhury; Su Q Wang; Kerby A Shedden; Robert C Dysko; Jocelyn E Wiggins; Roger C Wiggins
Journal:  Kidney Int       Date:  2011-09-21       Impact factor: 10.612

2.  Growth-dependent podocyte failure causes glomerulosclerosis.

Authors:  Akihiro Fukuda; Mahboob A Chowdhury; Madhusudan P Venkatareddy; Su Q Wang; Ryuzoh Nishizono; Tsukasa Suzuki; Larysa T Wickman; Jocelyn E Wiggins; Timothy Muchayi; Diane Fingar; Kerby A Shedden; Ken Inoki; Roger C Wiggins
Journal:  J Am Soc Nephrol       Date:  2012-07-05       Impact factor: 10.121

3.  Translationally controlled tumour protein is associated with podocyte hypertrophy in a mouse model of type 1 diabetes.

Authors:  D K Kim; B Y Nam; J J Li; J T Park; S H Lee; D H Kim; J Y Kim; H Y Kang; S H Han; T H Yoo; D S Han; S W Kang
Journal:  Diabetologia       Date:  2012-02-04       Impact factor: 10.122

4.  Estimating podocyte number and density using a single histologic section.

Authors:  Madhusudan Venkatareddy; Su Wang; Yan Yang; Sanjeevkumar Patel; Larysa Wickman; Ryuzoh Nishizono; Mahboob Chowdhury; Jeffrey Hodgin; Paul A Wiggins; Roger C Wiggins
Journal:  J Am Soc Nephrol       Date:  2013-12-19       Impact factor: 10.121

Review 5.  When to initiate ACEI/ARB therapy in patients with type 1 and 2 diabetes.

Authors:  Kevin V Lemley
Journal:  Pediatr Nephrol       Date:  2010-03-30       Impact factor: 3.714

Review 6.  Diabetic kidney disease: a role for advanced glycation end-product receptor 1 (AGE-R1)?

Authors:  Aowen Zhuang; Josephine M Forbes
Journal:  Glycoconj J       Date:  2016-06-06       Impact factor: 2.916

7.  Gas1 expression in parietal cells of Bowman's capsule in experimental diabetic nephropathy.

Authors:  Brenda I Luna-Antonio; Rafael Rodriguez-Muñoz; Carmen Namorado-Tonix; Paula Vergara; Jose Segovia; Jose L Reyes
Journal:  Histochem Cell Biol       Date:  2017-03-18       Impact factor: 4.304

8.  A novel mouse model of podocyte depletion.

Authors:  L Wang; Y Tang; D N Howell; P Ruiz; R F Spurney
Journal:  Nephron Exp Nephrol       Date:  2012-10-19

Review 9.  Clinical therapeutic strategies for early stage of diabetic kidney disease.

Authors:  Munehiro Kitada; Keizo Kanasaki; Daisuke Koya
Journal:  World J Diabetes       Date:  2014-06-15

Review 10.  The sweeter side of ACE2: physiological evidence for a role in diabetes.

Authors:  Sharell M Bindom; Eric Lazartigues
Journal:  Mol Cell Endocrinol       Date:  2008-10-01       Impact factor: 4.102

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.